China News
-
TenNor receives FDA ODD for treating prosthetic joint infections
China | News | 0 Comment | 22 Jan, 2020
China based TenNor Therapeutics, a clinical-stage, global biopharmaceutical company has received FDA Orphan Drug Designa...Read more
-
Chi-Med to stop pancreatic cancer trial upon early success
China | News | 0 Comment | 21 Jan, 2020
Hutchison China MediTech has announced that the independent Data Monitoring Committee (“IDMC”) of the P...Read more
-
Mindray to improve diagnostic confidence
China | News | 0 Comment | 20 Jan, 2020
China headquartered Mindray Medical, a leading global provider of medical devices and solutions, announces the release o...Read more
-
MEVION S250i Selected for New Proton Therapy Center at Chinese Hospital
China | News | 0 Comment | 20 Jan, 2020
Mevion Medical Systems has signed an agreement to sell a HyperSCAN® pen-scanning scanner to Jinshazhou Hos...Read more
-
Eisai launches anti cancer agent Halaven in China
China | News | 0 Comment | 17 Jan, 2020
Japan headquartered Eisai Co., Ltd. has announced that it has launched the in-house developed anticancer agent Halaven&r...Read more
-
FDF China to boost Chinese pharmaceutical enterprises
China | News | 0 Comment | 16 Jan, 2020
FDF China, collocated with CPhI China, will be held from June 22-24, 2020 at Shanghai New International Expo C...Read more
-
WuXi Biologics and Bayer enter into acquisition agreement
China | News | 0 Comment | 16 Jan, 2020
WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions fo...Read more
-
Advances in Cell and Gene Therapy and Opportunities in China
China | Opinion | 0 Comment | 16 Jan, 2020
GenScript Biotech Corp., a leading global biotechnology group and a pioneer in the field of gene synthesis, held its ina...Read more
-
Tsinghua Amgen Scholars Program 2020 calls for application
China | News | 0 Comment | 15 Jan, 2020
The Amgen Scholars Program (ASP) is an international program funded by the Amgen Foundation with the direction of H...Read more
-
PPD expands clinical capabilities in China
China | News | 0 Comment | 15 Jan, 2020
PPD, Inc. ( PPD ) has expanded its China operations and leadership team to provide more international and Chin...Read more
-
Great Bay Bio injected with $2.5M of convertible note
China | News | 0 Comment | 14 Jan, 2020
Recently, Great Bay Bio signed off convertible note, and the company will be injected with 2.5 million USD by existing s...Read more
-
Adagene Completes $69 Million Series D Financing
China | News | 0 Comment | 14 Jan, 2020
China based Adagene, Inc., a clinical-stage, leading-edge oncology immunotherapy company driven by a powerful antibody d...Read more
-
EUSA Pharma, BeiGene partner for rare disease drug development
China | News | 0 Comment | 14 Jan, 2020
EUSA Pharma and BeiGene has announced that they have entered into an exclusive development and commercialization ag...Read more
-
Bio-Thera launches first Humira biosimilar in China
China | News | 0 Comment | 13 Jan, 2020
Bio-Thera Solutions, Ltd., a fully-integrated pharmaceutical company, has announced that QLETLI®, a biosimilar to Hu...Read more
-
WuXi Biologics inks strategic deal with Almirall in derma space
China | News | 0 Comment | 10 Jan, 2020
China based WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solut...Read more
-
Former Celgene Chairman and CEO Joins Antengene Board of Directors
China | News | 0 Comment | 09 Jan, 2020
The Antengene board has announced the appointment of Mr. Mark J. Alles as an independent director of the compa...Read more
-
Eisai launches antiepileptic drug in China
China | News | 0 Comment | 09 Jan, 2020
Japan based Eisai Co., Ltd. has announced that it has launched the in-house discovered and developed antiepileptic drug ...Read more
-
CStone initiates CS1001 trial to treat ESCC in China
China | News | 0 Comment | 08 Jan, 2020
CStone Pharmaceuticals has announced that the first patient has been dosed in the Phase III GEMSTONE-304 study of the Co...Read more
